{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:41:14Z","timestamp":1770900074372,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejim.2017.05.017","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:30:21Z","timestamp":1496277021000},"page":"62-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapy"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2115-6576","authenticated-orcid":false,"given":"Anca","family":"Negovan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela","family":"Iancu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriu","family":"Moldovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinga","family":"S\u00e0rk\u00e0ny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Bataga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Mocan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioan","family":"\u021ailea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Banescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9678","key":"10.1016\/j.ejim.2017.05.017_bb0005","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejim.2017.05.017_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/annonc\/mdu225","article-title":"Estimates of benefits and harms of prophylactic use of aspirin in the general population","volume":"26","author":"Cuzick","year":"2015","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ejim.2017.05.017_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrgastro.2011.97","article-title":"Gastrointestinal effects of aspirin","volume":"8","author":"Sostres","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ejim.2017.05.017_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7015-4-22","article-title":"Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications","volume":"20","author":"Hern\u00e1ndez-D\u00edaz","year":"2006","journal-title":"BMC Med"},{"issue":"18","key":"10.1016\/j.ejim.2017.05.017_bb0025","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/CIRCULATIONAHA.108.191087","volume":"118","author":"Bhatt","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejim.2017.05.017_bb0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"European Helicobacter Study Group. Management of Helicobacter pylori infection\u2014the Maastricht IV\/ Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ejim.2017.05.017_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bpg.2012.01.011","article-title":"Risk factors for gastrointestinal bleeding associated with low-dose aspirin","volume":"26","author":"Valkhoff","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejim.2017.05.017_bb0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1185\/030079907X162656","article-title":"Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment","volume":"23","author":"Lanas","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"1A","key":"10.1016\/j.ejim.2017.05.017_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9343(84)80014-5","article-title":"Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin and other NSAIDs","volume":"77","author":"Lanza","year":"1984","journal-title":"Am J Med"},{"issue":"17","key":"10.1016\/j.ejim.2017.05.017_bb0050","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.3748\/wjg.v21.i17.5382","article-title":"Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries","volume":"21","author":"Mo","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"23","key":"10.1016\/j.ejim.2017.05.017_bb0055","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2169\/internalmedicine.49.3824","article-title":"Low-dose aspirin-induced gastroduodenal mucosal injury in Japanese patients with arteriosclerotic disease","volume":"49","author":"Tamura","year":"2010","journal-title":"Intern Med"},{"issue":"26","key":"10.1016\/j.ejim.2017.05.017_bb0060","doi-asserted-by":"crossref","first-page":"e1047","DOI":"10.1097\/MD.0000000000001047","article-title":"Investigation of gastroduodenal mucosal injury in Japanese asymptomatic antiplatelet drug users","volume":"94","author":"Sogabe","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"28","key":"10.1016\/j.ejim.2017.05.017_bb0065","first-page":"9439","article-title":"Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and\/or low-dose aspirin use: old question new insights","volume":"20","author":"Sostres","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejim.2017.05.017_bb0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bpg.2012.01.006","article-title":"Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice","volume":"26","author":"Leung Ki","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejim.2017.05.017_bb0075","doi-asserted-by":"crossref","first-page":"258","DOI":"10.15403\/jgld.2014.1121.252.mdr","article-title":"Influence of MDR1 C3435T, CYP2C19*2 and CYP2C19*3 gene polymorphisms and clinical characteristics on the severity of gastric lesions: a case-control study","volume":"25","author":"Negovan","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"issue":"2","key":"10.1016\/j.ejim.2017.05.017_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/rrlm-2015-0017","article-title":"AGT A-20C (rs5050) gene polymorphism and ulcer occurrence in patients treated with low-dose aspirin: a case-control study","volume":"23","author":"Negovan","year":"2015","journal-title":"Revista Romana de Medicina de Laborator"},{"issue":"Suppl. 2","key":"10.1016\/j.ejim.2017.05.017_bb0085","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1111\/j.1440-1746.2008.05411.x","article-title":"Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease","volume":"23","author":"Nema","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ejim.2017.05.017_bb0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/1756-0500-6-455","article-title":"Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers","volume":"12","author":"Kawamura","year":"2013","journal-title":"BMC Res Notes"},{"issue":"9","key":"10.1016\/j.ejim.2017.05.017_bb0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2036.2005.02649.x","article-title":"Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin","volume":"22","author":"Yeomans","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.ejim.2017.05.017_bb0100","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2010.04415.x","article-title":"Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin","volume":"32","author":"Fletcher","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"25","key":"10.1016\/j.ejim.2017.05.017_bb0105","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.3748\/wjg.v21.i25.7709","article-title":"Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury","volume":"21","author":"Iijima","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2017.05.017_bb0110","doi-asserted-by":"crossref","first-page":"7230626","DOI":"10.1155\/2016\/7230626","article-title":"Clinical risk factors for gastroduodenal ulcer in Romanian low-dose aspirin consumers","volume":"2016","author":"Negovan","year":"2016","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"10.1016\/j.ejim.2017.05.017_bb0115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.dld.2013.12.017","article-title":"Changing prevalence patterns in endoscopic and histological diagnosis of gastritis? Data from a cross-sectional Central European multicentre study","volume":"46","author":"Wolf","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.ejim.2017.05.017_bb0120","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MEG.0000000000000065","article-title":"Prevalence of gastric precancerous conditions: a systematic review and meta-analysis","volume":"26","author":"Marques-Silva","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ejim.2017.05.017_bb0125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/gut.2005.071779","article-title":"Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection","volume":"55","author":"El-Omar","year":"2006","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.ejim.2017.05.017_bb0130","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00535-012-0598-8","article-title":"Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level","volume":"47","author":"Iijima","year":"2012","journal-title":"J Gastroenterol"},{"issue":"12","key":"10.1016\/j.ejim.2017.05.017_bb0135","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJM200009213431202","article-title":"Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding","volume":"343","author":"Lanas","year":"2000","journal-title":"N Engl J Med"},{"issue":"96","key":"10.1016\/j.ejim.2017.05.017_bb0140","first-page":"1665","article-title":"Clinical study of upper gastrointestinal bleeding associated with low-dose aspirin in Japanese patients","volume":"56","author":"Okada","year":"2009","journal-title":"Hepatogastroenterology"},{"issue":"18","key":"10.1016\/j.ejim.2017.05.017_bb0145","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.3748\/wjg.v12.i18.2923","article-title":"Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease","volume":"12","author":"Ng","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.ejim.2017.05.017_bb0150","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1053\/j.gastro.2013.02.040","article-title":"Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding","volume":"144","author":"Crooks","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ejim.2017.05.017_bb0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10654-014-9971-7","article-title":"Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population","volume":"30","author":"Thorat","year":"2015","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.ejim.2017.05.017_bb0160","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2036.2002.01230.x","article-title":"Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin","volume":"16","author":"Lanas","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.ejim.2017.05.017_bb0165","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1046\/j.1365-2036.2002.01355.x","article-title":"Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases","volume":"16","author":"Serrano","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ejim.2017.05.017_bb0170","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3892\/ijmm.2014.1786","article-title":"Cigarette smoking and gastrointestinal diseases: the causal relationship and underlying molecular mechanisms (review)","volume":"34","author":"Li","year":"2014","journal-title":"Int J Mol Med"},{"issue":"3","key":"10.1016\/j.ejim.2017.05.017_bb0175","doi-asserted-by":"crossref","first-page":"e0151332","DOI":"10.1371\/journal.pone.0151332","article-title":"Acute middle gastrointestinal bleeding risk associated with NSAIDs, antithrombotic drugs, and PPIs: a multicenter case-control study","volume":"11","author":"Nagata","year":"2016","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.ejim.2017.05.017_bb0180","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/CIRCULATIONAHA.109.895342","volume":"121","author":"Berger","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ejim.2017.05.017_bb0185","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jfma.2011.11.028","article-title":"Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy","volume":"111","author":"Tsai","year":"2012","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.ejim.2017.05.017_bb0190","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fphar.2010.00126","article-title":"Risk of upper gastrointestinal bleeding in a cohort of new users of low-dose ASA for secondary prevention of cardiovascular outcomes","volume":"1","author":"Cea Soriano","year":"2010","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ejim.2017.05.017_bb0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/annonc\/mdu225","article-title":"Estimates of benefits and harms of prophylactic use of aspirin in the general population","volume":"26","author":"Cuzick","year":"2014","journal-title":"Ann Oncol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517302157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517302157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T04:06:46Z","timestamp":1602216406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517302157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":39,"alternative-id":["S0953620517302157"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.05.017","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}